New target for treating diabetic neuropathy identified

01 May 2018


A study, published in the Journal of Clinical Investigation, has identified that inhibition of a chemokine receptor can reverse nerve degeneration and reduce pain in a model of diabetic neuropathy.

Medical Xpress


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story